What is the 13F Pro Quality Score for ATEC?

13F Pro ranks Alphatec Holdings, Inc. (ATEC) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ATEC's current score at https://13fpro.ai/research/ATEC (free sign-up required for the full ranking).

Which hedge funds own the most ATEC stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of ATEC include BlackRock,, AMERICAN CENTURY COMPANIES, UBS Group AG. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/ATEC as soon as new 13F filings post.

Where does 13F Pro source ATEC data?

All Alphatec Holdings, Inc. fundamentals and ownership data come directly from SEC EDGAR. Alphatec Holdings, Inc. files with the SEC under CIK 1350653. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ATEC in?

Alphatec Holdings, Inc. (ATEC) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ATEC research updated on 13F Pro?

ATEC's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Alphatec Holdings, Inc.(ATEC)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1350653 ATEC stock profile & AI dashboard →

13F Pro Quality Score

37.7/100

Rank #2,041 of 2,879 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

84.0/100

Profitability

18.2/100

Balance Sheet

11.8/100

Earnings Quality

30.0/100

Free Cash Flow

28.8/100

Institutional Flow

45.5/100

Revenue Scale

43.9/100

Dilution Risk

17.2/100

ATEC Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Alphatec Holdings, Inc. (ATEC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ATEC at 37.7/100 on a 32-signal composite quality model, placing it at rank #2,041 of 2,879 stocks — the bottom half of the AI-ranked universe. ATEC scores in the top quartile across revenue growth (84.0). Areas of concern include balance sheet strength (11.8) and profitability (18.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 17.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Alphatec Holdings, Inc. reports quarterly revenue of $192.1M, net income of $-33.9M, an operating margin of -11.8%. Top institutional holders of ATEC by reported 13-F value include BlackRock,, AMERICAN CENTURY COMPANIES, UBS Group AG, based on the most recent SEC filings. ATEC trades on the Nasdaq exchange and files with the SEC under CIK 1350653. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ATEC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alphatec Holdings, Inc. directly from SEC EDGAR. Alphatec Holdings, Inc.'s 13F Pro composite quality score has ranged between 23 and 39 since 2021, currently 37.7 — an improving long-term trajectory across 14 quarterly and live scoring snapshots.

✦

Fun facts about Alphatec Holdings, Inc.

Quirks, history, and lore behind ATEC — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. medical device company · listed on Nasdaq · headquartered in Southern California · focused on surgical implants.
2
The Numbers
Annual revenue in the range of $200–300 million — small-cap territory — yet it has been posting double-digit growth as it takes share from much larger rivals.
3
The History
The company went through a significant strategic pivot in the late 2010s, rebranding and refocusing entirely on spine surgery after shedding unrelated businesses.
4
The Secret
Its differentiating bet is on lateral and minimally invasive spine procedures — approaches that promise faster patient recovery and shorter hospital stays than traditional open surgery.
5
The Lore
The company recruited a well-known spine surgery evangelist as its executive chairman, whose personal reputation in the orthopedic world became a core part of the company's sales pitch to surgeons.
6
The Giveaway
Its ticker spells out a Greek letter, its name nods to technology, and its entire reason for being is fixing your spine — one lumbar at a time.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$192.1M

Net Income

Q1 2026

$-33.9M

Free Cash Flow

Q1 2026

$-10.8M

Operating Margin

Q1 2026

-11.8%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+26.8% YoY

$611.6MFY 2024

FY21 $243.2MFY22 $350.9MFY23 $482.3MFY24 $611.6M

Net Income

+13.1% YoY

$-162.1MFY 2024

FY21 $-143.0MFY22 $-151.3MFY23 $-186.6MFY24 $-162.1M

Operating Income

+21.5% YoY

$-136.2MFY 2024

FY21 $-128.1MFY22 $-147.0MFY23 $-173.4MFY24 $-136.2M

EPS (Diluted)

+26.6% YoY

$-1.13FY 2024

FY21 $-1.49FY22 $-1.46FY23 $-1.54FY24 $-1.13

Total Assets

-3.7% YoY

$775.7MFY 2024

FY21 $572.1MFY22 $521.0MFY23 $805.2MFY24 $775.7M

Total Debt

+12.2% YoY

$579.5MFY 2024

FY21 $327.5MFY22 $394.4MFY23 $516.5MFY24 $579.5M

Op. Cash Flow

+43.1% YoY

$-44.7MFY 2024

FY21 $-73.3MFY22 $-75.1MFY23 $-78.5MFY24 $-44.7M

Metric	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Revenue	$611.6M +26.8%	$482.3M +37.4%	$350.9M +44.3%	$243.2M +67.9%	$144.9M +27.7%	$113.4M
Net Income	$-162.1M +13.1%	$-186.6M -23.4%	$-151.3M -5.8%	$-143.0M -81.1%	$-79.0M -38.6%	$-57.0M
Operating Income	$-136.2M +21.5%	$-173.4M -18.0%	$-147.0M -14.8%	$-128.1M -117.6%	$-58.9M -24.5%	$-47.3M
EPS (Diluted)	$-1.13 +26.6%	$-1.54 -5.5%	$-1.46 +2.0%	$-1.49 -26.3%	$-1.18	—
Total Assets	$775.7M -3.7%	$805.2M +54.6%	$521.0M -8.9%	$572.1M +119.0%	$261.2M +53.7%	$169.9M
Total Debt	$579.5M +12.2%	$516.5M +31.0%	$394.4M +20.4%	$327.5M +498.7%	$54.7M -12.1%	$62.2M
Operating Cash Flow	$-44.7M +43.1%	$-78.5M -4.5%	$-75.1M -2.5%	$-73.3M -58.0%	$-46.4M -40.1%	$-33.1M

AI Insight: ATEC Financial Trends

Revenue grew 46% year-over-year in Q1 2026, but operating losses widened and debt increased 27% over the past year.

• Revenue increased from $146M in Q2 2024 to $192M in Q1 2026, representing 31% growth over eight quarters.

• Operating losses improved significantly from -$44M in Q1 2025 to -$23M in Q1 2026.

• Total debt climbed from $554M in Q1 2025 to $704M in Q1 2026, a 27% increase.

⚠ Operating cash flow turned negative to $1M in Q1 2026 after three consecutive positive quarters.

⚠ Equity swung from $24M in Q2 2025 to -$5M in Q1 2026, indicating balance sheet pressure.

AI Insight: ATEC Ratio Trends

Alphatec's operating margin deteriorated to -11.8% in Q1 2026 after improving to -4.1% in Q4 2025, reversing a multi-quarter profitability trend.

• Operating margin improved dramatically from -26.2% in Q1 2025 to -4.1% in Q4 2025 before weakening to -11.8% in Q1 2026.

• ROIC recovered from -37.9% in Q1 2025 to -5.0% in Q4 2025, representing significant operational improvement over three quarters.

• Debt-to-equity ratio decreased from 30.61 in Q2 2024 to 23.46 in Q2 2025, indicating reduced leverage.

⚠ Operating margin reversed from -4.1% in Q4 2025 to -11.8% in Q1 2026, breaking improvement trajectory.

⚠ ROIC deteriorated from -5.0% in Q4 2025 to -12.9% in Q1 2026, suggesting operational setback.

Get alerted when ATEC's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Alphatec Holdings, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ATEC

BlackRock, Inc.
$109.8M10,088,182 sh
AMERICAN CENTURY COMPANIES INC
$69.9M6,424,777 sh
UBS Group AG
$56.7M5,211,600 sh
VANGUARD CAPITAL MANAGEMENT LLC
$53.5M4,913,779 sh
ROYAL BANK OF CANADA
$49.1M4,516,592 sh
BNP Paribas Asset Management Holding S.A.
$39.3M3,616,330 sh
STATE STREET CORP
$33.0M3,031,164 sh
GEODE CAPITAL MANAGEMENT, LLC
$31.6M2,906,422 sh
Nuveen, LLC
$31.0M2,849,413 sh
MILLENNIUM MANAGEMENT LLC
$30.6M2,809,545 sh

Fund	Value	Shares
BlackRock, Inc.	$109.8M	10,088,182
AMERICAN CENTURY COMPANIES INC	$69.9M	6,424,777
UBS Group AG	$56.7M	5,211,600
VANGUARD CAPITAL MANAGEMENT LLC	$53.5M	4,913,779
ROYAL BANK OF CANADA	$49.1M	4,516,592
BNP Paribas Asset Management Holding S.A.	$39.3M	3,616,330
STATE STREET CORP	$33.0M	3,031,164
GEODE CAPITAL MANAGEMENT, LLC	$31.6M	2,906,422
Nuveen, LLC	$31.0M	2,849,413
MILLENNIUM MANAGEMENT LLC	$30.6M	2,809,545

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ATEC on your watchlist

Track score changes the day Alphatec Holdings, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ATEC a good stock to buy?

13F Pro's AI-powered analysis of Alphatec Holdings, Inc. (ATEC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ATEC are available on the ATEC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own ATEC?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ATEC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Alphatec Holdings, Inc.'s investment landscape.